Technology & Science
Aug. 5, 2010
Biotech IPO Proves Disappointing
The stock market has been tough on life science companies this year and San Diego-based Trius Therapeutics Inc.'s initial public offering on Tuesday was no exception.
Daily Journal Staff Writer
SAN DIEGO - The stock market has been tough on life science companies this year and San Diego-based Trius Therapeutics Inc.'s initial public offering on Tuesday was no exception.
Trius cut the initial price for its stock and delayed its IPO that originally was planned for last week.
Trius said in filings with the Securities and Exchange Commission last month that it ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In